ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
KNE Kane Biotech Inc
- 0.115
- +0.005+4.55%
15min DelayMarket Closed Dec 13 16:00 ET
15.81MMarket Cap2.30P/E (TTM)
0.115High0.110Low36.00KVolume0.115Open0.110Pre Close4.10KTurnover0.17052wk High0.04%Turnover Ratio137.51MShares0.06552wk Low0.05EPS TTM10.02MFloat Cap4.500Historical HighLossP/E (Static)87.14MShs Float0.050Historical Low-0.04EPS LYR4.55%Amplitude--Dividend TTM-23.00P/B1Lot Size--Div YieldTTM
Kane Biotech Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,650.21%1.28M | 2,045.50%620.44K | 47.11%51.89K | -4.95%148.98K | 103.18%57.79K | -95.28%27K | -96.56%28.92K | -93.76%35.27K | -90.25%156.73K | -542.07%-1.82M |
| Operating revenue | 4,650.21%1.28M | 2,045.50%620.44K | 47.11%51.89K | -4.95%148.98K | 103.18%57.79K | -95.28%27K | -91.48%28.92K | -93.76%35.27K | -90.25%156.73K | -542.07%-1.82M |
| Cost of revenue | 20,513.44%723.94K | 4,720.86%259.94K | 66.27%11.84K | -11.62%39.51K | 102.80%23.49K | -98.84%3.51K | 5.39K | -98.14%7.12K | -95.70%44.7K | -474.11%-839.42K |
| Gross profit | 2,278.59%558.75K | 1,432.33%360.5K | 42.26%40.05K | -2.28%109.47K | 103.50%34.3K | -91.29%23.49K | -96.32%23.53K | -84.67%28.15K | -80.29%112.03K | -623.47%-980.55K |
| Operating expense | 17.62%1.17M | 433.12%1.46M | 35.72%1.23M | -2.88%3.47M | 488.06%1.29M | -11.28%994.8K | -79.84%274.5K | -36.28%904.92K | -34.53%3.57M | -122.35%-333.11K |
| Selling and administrative expenses | 37.66%986.82K | 347.65%978.48K | 30.14%786.85K | -4.76%2.41M | 272.06%872.9K | -29.78%716.84K | --218.58K | -43.40%604.64K | -37.82%2.53M | -153.36%-507.34K |
| -General and administrative expense | 37.66%986.82K | 347.65%978.48K | 30.14%786.85K | -4.76%2.41M | 272.06%872.9K | -29.78%716.84K | --218.58K | -43.40%604.64K | -37.82%2.53M | -153.36%-507.34K |
| Research and development costs | -34.08%183.24K | 767.21%484.92K | 46.96%441.3K | 1.73%1.05M | 140.91%419.74K | 176.55%277.96K | -86.34%55.92K | -14.66%300.29K | -24.78%1.04M | -67.73%174.23K |
| Operating profit | 37.06%-611.31K | -339.46%-1.1M | -35.51%-1.19M | 2.90%-3.36M | -94.36%-1.26M | -14.06%-971.31K | 65.24%-250.97K | 29.09%-876.77K | 29.20%-3.46M | 50.33%-647.44K |
| Net non-operating interest income (expenses) | 77.48%-61.52K | 76.43%-100.77K | -33.65%-317.05K | -50.94%-1.21M | 21.77%-271.51K | -30.97%-273.17K | -427.46K | -105.46%-237.22K | -172.40%-801.2K | -222.72%-347.08K |
| Non-operating interest income | 141.10%3.25K | --0 | --473 | -63.36%5.67K | 105.23%3.41K | -95.38%1.35K | --912 | --0 | -87.32%15.46K | -357.03%-65.1K |
| Non-operating interest expense | -76.40%64.77K | -76.48%100.77K | 33.85%317.52K | 48.78%1.22M | -2.51%274.91K | 15.46%274.52K | --428.37K | 68.27%237.22K | 96.29%816.66K | 112.22%281.98K |
| Other net income (expenses) | -1,635.19%-5.8K | -259.60%-12.33K | 43,596.15%11.36K | -98.15%4.39K | 117.97%7.42K | -98.21%378 | -3.43K | -99.99%26 | -27.64%237.17K | -126.84%-41.27K |
| Gain on sale of security | -1,635.19%-5.8K | -259.60%-12.33K | 403.45%11.36K | 103.50%621 | 122.84%7.42K | -98.11%378 | ---3.43K | -62.57%-3.74K | -546.04%-17.73K | -558.30%-32.48K |
| Other non-operating income (expenses) | ---- | ---- | ---- | -98.52%3.77K | --0 | ---- | ---- | -98.13%3.77K | -21.28%254.9K | -105.99%-8.79K |
| Income before tax | 45.45%-678.64K | -78.34%-1.22M | -34.10%-1.49M | -13.44%-4.56M | -46.98%-1.52M | -19.73%-1.24M | -681.86K | 3.32%-1.11M | 17.08%-4.02M | 17.61%-1.04M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 58.09%-605.81K | 1,050.70%9.2M | -8.21%-1.35M | -37.82%-5.27M | -92.32%-1.61M | -39.12%-1.45M | -21.81%-967.91K | -8.03%-1.24M | 21.15%-3.82M | 33.33%-838.15K |
| Net income continuous operations | 45.45%-678.64K | -78.34%-1.22M | -34.10%-1.49M | -13.44%-4.56M | -46.98%-1.52M | -19.73%-1.24M | 14.19%-681.86K | 3.32%-1.11M | 17.08%-4.02M | 17.61%-1.04M |
| Net income discontinuous operations | 136.15%72.82K | 3,741.99%10.42M | 212.42%146.96K | -458.08%-707.71K | ---89.47K | ---201.47K | ---286.05K | ---130.72K | --197.64K | ---- |
| Noncontrolling interests | 0 | 120.26%19.32K | 212.42%49K | -458.09%-235.95K | -193.99%-29.83K | -142.74%-67.17K | -95.37K | -0.02%-43.58K | 126.86%65.89K | 172.55%31.74K |
| Net income attributable to the company | 56.05%-605.81K | 1,152.39%9.18M | -16.21%-1.4M | -29.41%-5.03M | -81.87%-1.58M | -36.28%-1.38M | 3.05%-872.54K | -8.34%-1.2M | 15.52%-3.89M | 31.44%-869.89K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 56.05%-605.81K | 1,152.39%9.18M | -16.21%-1.4M | -29.41%-5.03M | -81.87%-1.58M | -36.28%-1.38M | 3.05%-872.54K | -8.34%-1.2M | 15.52%-3.89M | 31.44%-869.89K |
| Diluted earnings per share | 58.35%-0.0045 | 450.00%0.07 | 0.00%-0.01 | -33.33%-0.04 | 0 | -8.71%-0.0109 | -100.00%-0.02 | 0.00%-0.01 | 25.00%-0.03 | 0 |
| Basic earnings per share | 58.35%-0.0045 | 400.00%0.06 | 0.00%-0.01 | -33.33%-0.04 | 0 | -8.71%-0.0109 | -100.00%-0.02 | 0.00%-0.01 | 25.00%-0.03 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.